Overview
Takao Hikita practices practicing medicine in Bad Nauheim, Germany.
His clinical expertise encompasses Pendred Syndrome, Rhabdomyosarcoma, Angiosarcoma, and Lung Metastases.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takao Hikita
Is Takao Hikita a top-rated expert for Pendred Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Takao Hikita is classified as an Experienced expert for Pendred Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takao Hikita participate in research or clinical trials?
Yes. Takao Hikita has published 11 articles and abstracts on conditions like Pendred Syndrome. You can view a list of Takao Hikita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiosarcomaMr. Hikita isExperienced. Learn about Angiosarcoma.
- Lung MetastasesMr. Hikita isExperienced. Learn about Lung Metastases.
- Pendred SyndromeMr. Hikita isExperienced. Learn about Pendred Syndrome.
- RhabdomyosarcomaMr. Hikita isExperienced. Learn about Rhabdomyosarcoma.